You should consider the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund launched on February 5, 2001. An increasingly popular option among retail and institutional investors, ...

The Ulcerative Colitis treatment paradigm is undergoing a dynamic evolution, marked by increasing therapeutic interventions ...

The U.S. stock market is climbing toward records after data suggested inflation across the country was a touch better last ...

Immune effector cell-associated neurotoxicity syndrome is a complication of chimeric antigen receptor T-cell therapy.The ...

DelveInsight's Tumor-Infiltrating Lymphocyte Therapies Market Size, Target Population, Competitive Landscape & Market ...

DelveInsight's“ Triple Negative Breast Cancer Pipeline Insight 2025” report provides comprehensive insights about 165+ ...

With the first half of 2025 in the rearview mirror, the government’s continued focus on False Claims Act (FCA) enforcement shows no signs of ...

Stay with Moneycontrol to get real time updates on US MARKET share price, top gainers, top losers and market insights.

Over the last ten years, cell-based immunotherapy has emerged as a promising approach for treating solid tumors. Several companies, including Iovance Biotherapeutics, Obsidian Therapeutics, ...